Menu ×


Women’s Health Diagnostics Market Segmentation by Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy & Fertility Testing, Sexually Transmitted Disease Testing, and Others); and by End User (Hospitals, Clinics, and Home Care) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Extensive insights into the Growth of Women’s Health Diagnostics Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


  • August 2021- Siemens Healthineers and TeamViewer announced a partnership for enabling new digital models to combat the shortage of skilled radiology technologists in healthcare facilities.

  • September 2020- GE Healthcare unveiled Voluson SWIFT, an AI-enhanced women’s health ultrasound system with industry first auto recognition tools to improve efficiency.

Global Women’s Health Diagnostics Market Highlights Over 2022 - 2031

The global women’s health diagnostics market is estimated to garner a large amount of revenue by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the rising awareness levels about various health disorders across the globe, and increasing prevalence of lifestyle and chronic diseases among women. According to the Pan American Health Organization, in 2019, a total of 534,242 deaths occurred due to chronic respiratory diseases in the region of the Americas alone, out of which 266,725, i.e., 50 percent deaths were among women. Along with these, growing occurrence of infectious disorders such as hepatitis and HIV in women all around the world is also expected to boost the growth of the market significantly in the forthcoming years. Furthermore, since the past few years, immunoassays, a highly popular platforms for diagnosing several conditions among women, are receiving surge in the number of regulatory approvals from medical bodies worldwide. This in turn is projected to offer ample growth opportunities to the market in the near future.

Women’s Health Diagnostics Market Graph

Get more information on this reportDownload Sample PDF

The market is segmented by application into breast cancer, infectious disease testing, osteoporosis testing, pregnancy & fertility testing, sexually transmitted disease testing, and others. Out of these, the breast cancer segment is anticipated to hold the largest share in the global women’s health diagnostics market. This can be accounted to the increasing burden of breast cancer globally, and rise in investments in research and development for cancer diagnosis. Apart from these, provision of reimbursement and insurance coverage for breast cancer diagnosis in developed nations is also assessed to drive growth to the market segment in the future. Additionally, on the basis of end user, the home care segment is assessed to observe robust growth during the forecast period owing to the growing preference for using self-testing kits amongst women for various conditions, such as ovulation and pregnancy, as a result of their convenience of diagnosis. 

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Women’s Health Diagnostics Market Regional Synopsis

Regionally, the global women’s health diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in Asia Pacific is estimated to witness noteworthy growth over the forecast period on the back of the large patient pool, and surging improvements in the healthcare infrastructure in the region. Moreover, the market in North America is expected to grab the largest share during the forecast period, which can be credited primarily to the growing occurrence of cancer among women in the region. As per the National Cancer Institute, the rate of new cases of female breast cancer in the United States was 129.1 per 100,000 women per year. The rate is age-adjusted and based on 2014–2018 cases and 2015–2019 deaths. In addition, increasing demand for fertility test monitors, and high emphasis of pharmaceutical manufacturers on expanding their presence are also predicted to bolster the growth of the market in the region in the coming years.

Women’s Health Diagnostics Market Share Image

Get more information on this reportDownload Sample PDF

The global women’s health diagnostics market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global women’s health diagnostics market includes the following segments:

By Application

  • Breast Cancer
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy & Fertility Testing
  • Sexually Transmitted Disease Testing
  • Others

By End User

  • Hospitals
  • Clinics
  • Home Care

Growth Drivers

  • Rising Awareness Levels About Various Health Disorders Globally
  • Increasing Prevalence of Lifestyle and Chronic Diseases Among Women


  • High Cost of Diagnostic Imaging Procedures and Systems

Top Featured Companies Dominating the Market

  • Siemens AG
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • F. Hoffmann-La Roche Ltd.
  • Cardinal Health, Inc.
  • General Electric Company
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Quest Diagnostics, Inc.
  • PerkinElmer Inc.
  • Alere Inc.
  • Biomérieux SA


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved